APO 25
Pill imprint APO 25 has been identified as Zonisamide 25 mg.
Zonisamide is used in the treatment of seizures; migraine prevention; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy.
Zonisamide 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Zonisamide Images
- Imprint:
-
APO
25 - Strength:
- 25 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-2545
Advertisement
More Zonisamide resources
- Zonisamide (Wolters Kluwer)
- zonisamide (Cerner Multum)
- zonisamide (Micromedex) - Includes Dosage Information
- Zonisamide (AHFS DI)
- Zonisamide Capsules (FDA)
- Zonisamide (Wolters Kluwer)
Search Again
